TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,240,623 | -7.6% | 2,932,606 | 0.0% | 10.94% | +16.8% |
| Q2 2023 | $8,915,122 | +61.7% | 2,932,606 | 0.0% | 9.37% | +40.4% |
| Q1 2023 | $5,513,299 | +84.3% | 2,932,606 | 0.0% | 6.67% | +68.6% |
| Q4 2022 | $2,991,258 | -61.2% | 2,932,606 | 0.0% | 3.96% | -64.7% |
| Q3 2022 | $7,713,000 | -41.7% | 2,932,606 | 0.0% | 11.20% | -39.0% |
| Q2 2022 | $13,226,000 | -54.2% | 2,932,606 | 0.0% | 18.36% | -32.3% |
| Q1 2022 | $28,857,000 | -35.6% | 2,932,606 | 0.0% | 27.11% | +31.4% |
| Q4 2021 | $44,840,000 | – | 2,932,606 | – | 20.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $8,240,623 | 10.94% |
| BML Capital Management, LLC | 2,000,000 | $5,620,000 | 5.16% |
| Nantahala Capital Management | 2,953,129 | $8,298,292 | 0.71% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $2,810,000 | 0.51% |
| Acuitas Investments, LLC | 194,547 | $546,677 | 0.32% |
| Affinity Asset Advisors, LLC | 400,000 | $1,124,000 | 0.32% |
| RA Capital Management | 2,403,238 | $6,753,099 | 0.13% |
| Artal Group S.A. | 914,262 | $2,569 | 0.11% |
| Blackstone Inc. | 8,089,315 | $22,730,975 | 0.10% |
| QVT Financial LP | 589,314 | $1,655,972 | 0.09% |